Evidence map›Paper›PMID 38432234›Full record

ArticleThe Lancet. Microbe2024

Emergence of zoonotic sporotrichosis in Brazil: a genomic epidemiology study.

Amanda Ribeiro Dos Santos, Elizabeth Misas, Brian Min, Ngoc Le, Ujwal R Bagal, Lindsay A Parnell, D Joseph Sexton, Shawn R Lockhart, Marcia de Souza Carvalho Melhem, Juliana Possatto Fernandes Takahashi and 10 more

Open access · goldAbstract read
In one paragraph

Article in The Lancet. Microbe, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
10.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Assessing the persistence ofMicrobiology spectrum · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Biogenic Silver Nanoparticle: In vitro antifungal activity against Sporothrix brasiliensis.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Cryptic Diversity and Ecological Overlap inJournal of fungi (Basel, Switzerland) · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 2 countries.

Amanda Ribeiro Dos SantosMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA; School of Medicine, Universidade Federal de Mato Grosso do Sul, Campo Grande, Brazil.
Elizabeth MisasMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Brian MinMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Ngoc LeMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Ujwal R BagalMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Lindsay A ParnellMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.
D Joseph SextonMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Shawn R LockhartMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Marcia de Souza Carvalho MelhemSchool of Medicine, Universidade Federal de Mato Grosso do Sul, Campo Grande, Brazil; Parasitology and Mycology Center, Instituto Adolfo Lutz, São Paulo, Brazil.
Juliana Possatto Fernandes TakahashiSchool of Medicine, Universidade Federal de Mato Grosso do Sul, Campo Grande, Brazil; Parasitology and Mycology Center, Instituto Adolfo Lutz, São Paulo, Brazil.
Gabriel Manzi OliboniCoordenadoria de Controle de Doenças, Secretaria de Estado de Saúde, São Paulo, Brazil.
Lucas Xavier BonfietiParasitology and Mycology Center, Instituto Adolfo Lutz, São Paulo, Brazil.
Paola CappellanoMicrobiology Section, Grupo Fleury, São Paulo, Brazil.
Jorge Luiz Mello SampaioMicrobiology Section, Grupo Fleury, São Paulo, Brazil.
Lisandra Siufi AraujoSchool of Medicine, Universidade Federal de Mato Grosso do Sul, Campo Grande, Brazil; Central Public Health Laboratory of Mato Grosso do Sul, Secretaria de Estado de Saúde de Mato Grosso do Sul, Campo Grande, Brazil.
Hilton L Alves FilhoSchool of Medicine, Universidade Federal de Pelotas, Pelotas, Brazil.
James VenturiniSchool of Medicine, Universidade Federal de Mato Grosso do Sul, Campo Grande, Brazil.
Tom M ChillerMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Anastasia P LitvintsevaMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Nancy A ChowMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: nchow@cdc.gov.
Centers for Disease Control and Prevention · USFleury S.A. (Brazil) · BRInstituto Adolfo Lutz · BRSecretaria da Saúde · BRUniversidade Federal de Mato Grosso do Sul · BRUniversidade Federal de Pelotas · BR

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

backgroundZoonotic sporotrichosis is a neglected fungal disease, whereby outbreaks are primarily driven by Sporothrix brasiliensis and linked to cat-to-human transmission. To understand the emergence and spread of sporotrichosis in Brazil, the epicentre of the current epidemic in South America, we aimed to conduct whole-genome sequencing (WGS) to describe the genomic epidemiology.

methodsIn this genomic epidemiology study, we included Sporothrix spp isolates from sporotrichosis cases from Brazil, Colombia, and the USA. We conducted WGS using Illumina NovaSeq on isolates collected by three laboratories in Brazil from humans and cats with sporotrichosis between 2013 and 2022. All isolates that were confirmed to be Sporothrix genus by internal transcribed spacer or beta-tubulin PCR sequencing were included in this study. We downloaded eight Sporothrix genome sequences from the National Center for Biotechnology Information (six from Brazil, two from Colombia). Three Sporothrix spp genome sequences from the USA were generated by the US Centers for Disease Control and Prevention as part of this study. We did phylogenetic analyses and correlated geographical and temporal case distribution with genotypic features of Sporothrix spp isolates.

findings72 Sporothrix spp isolates from 55 human and 17 animal sporotrichosis cases were included: 67 (93%) were from Brazil, two (3%) from Colombia, and three (4%) from the USA. Cases spanned from 1999 to 2022. Most (61 [85%]) isolates were S brasiliensis, and all were reported from Brazil. Ten (14%) were Sporothrix schenckii and were reported from Brazil, USA, and Colombia. For S schenckii isolates, two distinct clades were observed wherein isolates clustered by geography. For S brasiliensis isolates, five clades separated by more than 100 000 single-nucleotide polymorphisms were observed. Among the five S brasiliensis clades, clades A and C contained isolates from both human and cat cases, and clade A contained isolates from six different states in Brazil. Compared with S brasiliensis isolates, larger genetic diversity was observed among S schenckii isolates from animal and human cases within a clade.

interpretationOur results suggest that the ongoing epidemic driven by S brasiliensis in Brazil represents several, independent emergence events followed by animal-to-animal and animal-to human transmission within and between Brazilian states. These results describe how S brasiliensis can emerge and spread within a country.

fundingCoordenação de Aperfeiçoamento de Pessoal de Nível Superior, Brazil; the São Paulo Research Foundation; Productivity in Research fellowships by the National Council for Scientific and Technological Development, and Ministry of Science and Technology of Brazil.

Indexed as

SporothrixSporotrichosisAnimalsBrazilDisease OutbreaksGenomicsHumansPhylogeny

Identifiers

PMID38432234
PMCPMC11487493
OpenAlexW4392304100

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.